Science Explorer Back to mapMap

Most cited papers from Rudolfinerhaus Hospital

What are the most cited papers from Rudolfinerhaus Hospital?

The most cited paper from Rudolfinerhaus Hospital is "Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial" (John Dormandy et al., 2005), with 4,157 citations. Next come "ESMO consensus guidelines for the management of patients with metastatic colorectal cancer" (3,512) and "EAU Guidelines on Interventional Treatment for Urolithiasis" (1,843).

Showing 50 of 60 papers. Every paper with more than 151 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial John Dormandy et al. · The Lancet Open access Oct 2005 4,157
2 ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Eric Van Cutsem et al. · Annals of Oncology Open access 5 Jul 2016 3,512
3 EAU Guidelines on Interventional Treatment for Urolithiasis Christian Türk, Aleš Petřík, Kemal Sarıca et al. · European Urology 4 Sep 2015 1,843
4 EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis Christian Türk, Aleš Petřík, Kemal Sarıca et al. · European Urology 29 Aug 2015 969
5 Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Juan W. Valle, Ivan Borbath, Shahid Ahmed Khan et al. · Annals of Oncology Open access Sep 2016 694
6 Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients Johannes Sch�ller, Jim Cassidy, Etienne F. Dumont et al. · Cancer Chemotherapy and Pharmacology 6 Mar 2000 669
7 Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth Sonja Kleffel et al. · Cell Open access Sep 2015 657
8 European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I S. Krege et al. · European Urology 14 Jan 2008 618
9 Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study John B. Buse, Michael Albrecht Nauck, Thomas M. Forst et al. · The Lancet 6 Nov 2012 567
10 Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Wolfgang Pf Miehsler, W Reinisch, E Valic et al. · Gut Open access 11 Mar 2004 482
11 Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea Guntram Schernthaner, Jorge Luiz Gross, Julio Rosenstock et al. · Diabetes Care Open access 6 Apr 2013 482
12 Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population Juergen Floege, Jae Bum Kim, Elizabeth Ireland et al. · Nephrology Dialysis Transplantation Open access 25 Apr 2010 479
13 Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke Robert Wilcox, Marie‐Germaine Bousser, D. J. Betteridge et al. · Stroke 9 Feb 2007 476
14 Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression Martina Sanlorenzo, Igor Vujic, ADIL I. DAUD et al. · JAMA Dermatology Open access 29 Jul 2015 456
15 A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes Julio Rosenstock, Melanie J. Davies, Philip Home et al. · Diabetologia Open access 15 Jan 2008 448
16 Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients H-G. Kopp, Christoph W. Kopp, Andreas Festa et al. · Arteriosclerosis Thrombosis and Vascular Biology Open access 29 Apr 2003 429
17 Diabetes Mellitus in Older People: Position Statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes Alan J. Sinclair, John Edward Morley, Leocadio Rodríguez‐Mañas et al. · Journal of the American Medical Directors Association Open access 28 Jun 2012 426
18 Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: EAU Guidelines Andreas A. Skolarikos, Michael Straub, Thomas Martin Knoll et al. · European Urology 20 Nov 2014 422
19 EAU Guidelines on Testicular Cancer: 2011 Update Peter Albers, Walter Albrecht, Ferrán Algaba et al. · European Urology 27 May 2011 410
20 Hypoglycemia and Cardiovascular Risks Brian M. Frier, Guntram Schernthaner, Simon R. Heller · Diabetes Care Open access 22 Apr 2011 377
21 Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls Christian A. Bannister, Sarah E. Holden, Sara Jenkins‐Jones et al. · Diabetes Obesity and Metabolism 7 Jul 2014 362
22 Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial Thomas Gruenberger, John A. Bridgewater, Ian Chau et al. · Annals of Oncology Open access 23 Dec 2014 361
23 The Immunology of Fibrosis Georg Wick, Cecilia Grundtman, Christina Mayerl et al. · Annual Review of Immunology ReviewOpen access 21 Mar 2013 335
24 Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype Mohammed Iqbal Hawa et al. · Diabetes Care Open access 18 Dec 2012 334
25 Recommendations on basic requirements for intensive care units: structural and organizational aspects Andreas Valentin, Patrick Ferdinande, ESICM Working Group on Quality Improvement · Intensive Care Medicine Open access 14 Sep 2011 333
26 Guidelines on Testicular Cancer Peter Albers, Walter Albrecht, Ferrán Algaba et al. · European Urology 19 Jul 2005 316
27 Reflux, Sleeve Dilation, and Barrett’s Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up Daniel Moritz Felsenreich, Ronald Kefurt, Martin Schermann et al. · Obesity Surgery 7 Jun 2017 303
28 Transplantation of the RPE in AMD Susanne Binder, Boris V. Stanzel, Ilse Krebs et al. · Progress in Retinal and Eye Research 8 Mar 2007 294
29 Paediatric Gastrointestinal Endoscopy Mike A. Thomson et al. · Journal of Pediatric Gastroenterology and Nutrition Open access 13 Sep 2016 286
30 Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study Kamlesh K. Khunti, Saud N. Alsifri, Ronnie Aronson et al. · Diabetes Obesity and Metabolism Open access 10 May 2016 280
31 Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM) Andrew Rhodes, Rui Paulo Moreno, Élie Azoulay et al. · Intensive Care Medicine Open access 26 Jan 2012 280
32 GUIDE study: double‐blind comparison of once‐daily gliclazide MR and glimepiride in type 2 diabetic patients Gerit-Holger Schernthaner, André Grimaldi, Umberto Di Mario et al. · European Journal of Clinical Investigation Open access Aug 2004 271
33 Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial Guntram Schernthaner, David Richard Matthews, Bernard H. Charbonnel et al. · The Journal of Clinical Endocrinology & Metabolism Dec 2004 269
34 Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism Gottfried Novacek et al. · Gastroenterology 14 Jun 2010 265
35 Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology 18 Apr 2008 253
36 Immunogenicity and Allergenic Potential of Animal and Human Insulins Guntram Schernthaner · Diabetes Care Dec 1993 251
37 Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study Birgit Gruenberger, Johannes Schueller, Ute Heubrandtner et al. · The Lancet Oncology 10 Nov 2010 245
38 Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo Christian Posch, Homayoun Moslehi, Luzviminda Feeney et al. · Proceedings of the National Academy of Sciences Open access 19 Feb 2013 238
39 Langerhans cell histiocytosis in children Jolie Krooks, Milen Minkov, Angela G. Weatherall · Journal of the American Academy of Dermatology 10 May 2018 236
40 Outcome of Transplantation of Autologous Retinal Pigment Epithelium in Age-Related Macular Degeneration: A Prospective Trial Susanne Binder, Ilse Krebs, R.-D Hilgers et al. · Investigative Ophthalmology & Visual Science 25 Oct 2004 234
41 One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes M Hanefeld, Paolo Brunetti, Guntram Schernthaner et al. · Diabetes Care 2004 231
42 Small-bowel neoplasms in patients undergoing video capsule endoscopy: a multicenter European study Emanuele Rondonotti, Marco Pennazio, Ervin Tóth et al. · Endoscopy Open access 8 May 2008 228
43 Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study Susanne Binder, ULRIKE STOLBA, Ilse Krebs et al. · American Journal of Ophthalmology Feb 2002 225
44 Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy Daniel Moritz Felsenreich, Felix Benedikt Langer, Ronald Kefurt et al. · Surgery for Obesity and Related Diseases 27 Feb 2016 221
45 Three-dimensional optical coherence tomography at 1050 nm versus 800 nm in retinal pathologies: enhanced performance and choroidal penetration in cataract patients Boris Považay, Boris Hermann, Angelika Unterhuber et al. · Journal of Biomedical Optics Open access 2007 211
46 Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women H Kopp, Katarzyna Krzyżanowska, Matthias Möhlig et al. · International Journal of Obesity 3 May 2005 191
47 Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Philip Home, Matthew C. Riddle, William T. Cefalu et al. · Diabetes Care Open access 10 May 2014 177
48 Intracavernous Injection of Prostaglandin E1 in Impotent Men Walter Stackl, Rudolf Hasun, Michael Marberger · The Journal of Urology Jul 1988 175
49 Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study David Richard Matthews, Bernard H. Charbonnel, M Hanefeld et al. · Diabetes/Metabolism Research and Reviews 15 Jun 2004 175
50 Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes Bernard H. Charbonnel, Guntram Schernthaner, Philip Brunetti et al. · Diabetologia Open access 12 May 2005 170

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.